Stay updated with breaking news from Sylvan Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juniper Biologics ("Juniper"), Singapore-based science-led pharmaceutical company focused on researching, developing, and commercializing novel therapies, celebrates another milestone as it received the award for Best Novel Therapy R&D and...
/PRNewswire/ -- Juniper Biologics ("Juniper"), a global science-led pharmaceutical company headquartered in Singapore, proudly announces its latest...
/PRNewswire/ -- Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, today announced its...
Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, today announced its agreement with Ping-An Shionogi Hong Kong, a group company of Shionogi & Co., Ltd, to license the rights to Ensitrelvir Fumaric Acid ("Ensitrelvir") for Singapore. Juniper Biologics has applied for private patient access with the Health Sciences Authority (HSA) of the Republic of Singapore for the indication of SARS-CoV-2 infection.
/PRNewswire/ -- Juniper Biologics, a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the...